Patent details

LUC00220 Product Name: Onasemnogene abeparvovec

Basic Information

Publication number:
LUC00220
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP171531569
Legal Status:
Active
Application number:
LUC00220
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/20/1443
Marketing Authorization Type:
Marketing Authorization Date:
18/05/2020
Marketing Authorization Status:
Accepted
Marketing Authorization Country:
Luxembourg (LU)

Dates

Filing date:
30/08/2021
First Marketing Authorization date:
18/05/2020
Grant date:
19/04/2024
Activation date:
30/09/2024
Publication date:
30/08/2021
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
30/09/2029
SPC Extension Expiration:
30/09/2029
Rejection date:
Withdrawal date:

Owner

From:
30/08/2021
 
 

Name:
The Trustees of The University of Pennsylvania
Address:
3600 Civic Center Boulevard, 9th Floor, Philadelphia, PA 19104, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
30/08/2021
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC1
Bulletin edition number:
2021/10
Publication date:
01/09/2021
Description:
Section C : Published requests for Supplementary Protection Certificates – I1 publication

2

Bulletin Heading:
SPC3
Bulletin edition number:
2024/12
Publication date:
01/10/2024
Description:
Section E : Supplementary Protection certificates entered into force – IA publication

3

Bulletin Heading:
SPC2
Bulletin edition number:
2024/06
Publication date:
06/05/2024
Description:
Section D : Granted supplementary protection certificates – I2 publication

Annual Fees

Annual Fee Due Date:
30/09/2026
Annual Fee Number:
23
Annual Fee Amount:
430 Euro
Expected Payer:
Last Annual Fee Payment Date:
12/09/2025
Last Annual Fee Paid Number:
22
Last Annual Fee Paid Amount:
420 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
31/08/2021 Outgoing Correspondence 1
19/04/2024 Publication 1
18/04/2024 Incoming Correspondence (Post) 1
19/04/2024 Certificate 1
22/04/2024 Outgoing Correspondence 1
30/08/2021 Summary of the product caracteristics 42
30/08/2021 Publication 1
30/08/2021 Application Form 3
30/08/2021 Marketing authorization 3
30/08/2021 MA publication 7